
Abagovomab
CAS No. 792921-10-9
Abagovomab( —— )
Catalog No. M36884 CAS No. 792921-10-9
Abagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal antibody produced by hybridoma cells in mice that targets the tumor-associated antigen CA-125 and is used to study ovarian cancer.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 324 | Get Quote |
![]() ![]() |
5MG | 534 | Get Quote |
![]() ![]() |
10MG | 744 | Get Quote |
![]() ![]() |
25MG | 1095 | Get Quote |
![]() ![]() |
50MG | 1463 | Get Quote |
![]() ![]() |
100MG | 1953 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameAbagovomab
-
NoteResearch use only, not for human use.
-
Brief DescriptionAbagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal antibody produced by hybridoma cells in mice that targets the tumor-associated antigen CA-125 and is used to study ovarian cancer.
-
DescriptionAbagovomab (Anti-Human CA-125 Recombinant Antibody) is a murine monoclonal anti-idiotypic antibody, against the tumor-associated antigen, CA-125. Abagovomab is generated by a mouse hybridoma, can imitate the human TAA, CA-125. Abagovomab can elicit humoral and cellular immune responses against ovarian cancer (oc).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number792921-10-9
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pfisterer J, et al. The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR. Ann Oncol. 2006 Oct;17(10):1568-77.?
molnova catalog



related products
-
Guaiol
(-)-Guaiol is a biocatalyst.
-
Diphenyl sulfide
Used as pesticide, medicine, dye intermediates.
-
SMS1-IN-1
SMS1-IN-1 is a potent inhibitor of sphingomyelin synthase 1 (SMS1, IC50 = 2.1 μM), and can be used in the atherosclerosis studies.